» Articles » PMID: 16206341

Autoimmune Disease is a Risk Factor for the Development of Non-Hodgkin's Lymphoma

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2005 Oct 6
PMID 16206341
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the relationship of prior autoimmune disease to the development of non-Hodgkin's lymphoma (NHL).

Methods: Patients with NHL (n = 278) seen from 1993 to 2002 were compared with a group of patients with other hematological disorders (controls, n = 317) seen at the same time. All patients were questioned about prior autoimmune disease. Comparisons between NHL patients and controls were based on analysis of a 2 2 table of counts using Fisher's exact test. Analysis of the effect of autoimmune disease on NHL status, controlling for other risk factors, was performed using logistic regression.

Results: Thirty-six (13%) NHL patients had a prior autoimmune disease compared to 5% of controls (p = 0.001). Sixty-nine percent of NHL patients with a prior autoimmune disease were female compared to 43% without a prior autoimmune disease, and this was similar in control patients, 69% and 48%, respectively. Twenty percent of all women with NHL had a history of autoimmune disease compared to 7% of women in the control group (p = 0.001). Nineteen of the NHL patients with autoimmune disease (56%) received immunosuppressive treatment compared to 5 (38%) in the controls.

Conclusion: Autoimmune disease may account in part for the increase in NHL, especially in women.

Citing Articles

Evaluating plasma antinuclear autoantibody profile as a prognostic biomarker in lymphoma.

Zheng C, Gao R, Wang Y, Han X BMC Cancer. 2024; 24(1):1451.

PMID: 39592969 PMC: 11590230. DOI: 10.1186/s12885-024-13198-2.


Autoimmune diseases and risk of non-Hodgkin lymphoma: A Mendelian randomisation study.

Shi X, Wallach J, Ma X, Rogne T medRxiv. 2024; .

PMID: 38343812 PMC: 10854352. DOI: 10.1101/2024.01.20.24301459.


Antinuclear Antibodies Are Associated with an Increased Risk of Diffuse Large B-Cell Lymphoma.

Frost E, Hofmann J, Huang W, Parks C, Frazer-Abel A, Deane K Cancers (Basel). 2023; 15(21).

PMID: 37958403 PMC: 10647241. DOI: 10.3390/cancers15215231.


An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.

Venturutti L, Rivas M, Pelzer B, Flumann R, Hansen J, Karagiannidis I Cancer Discov. 2022; 13(1):216-243.

PMID: 36264161 PMC: 9839622. DOI: 10.1158/2159-8290.CD-22-0561.


The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Venturutti L, Melnick A Blood. 2020; 136(20):2263-2274.

PMID: 32932517 PMC: 7702481. DOI: 10.1182/blood.2020005857.